CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net income	$ 137,309	$ 13,478
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for loan and lease losses	(6,561)	(4,990)
Depreciation and amortization	1,518	1,544
Write down of assets		1,759
Write down of other real estate, net of gain on sale	(584)	(33)
Amortization of other intangible assets	2,248	1,761
Net amortization of investment securities	3,962	3,530
Share-based compensation	1,168	976
Net gain on sales of residential loans	(4,128)	(2,977)
Proceeds from sales of loans held for sale	212,432	189,500
Originations of loans held for sale	(187,314)	(158,372)
Equity in earnings of unconsolidated subsidiaries	(28)	(46)
Increase in cash surrender value of bank-owned life insurance	(564)	(2,009)
Release of DTA valuation allowance	(119,802)
Net change in other assets and liabilities	(6,918)	(17,316)
Net cash provided by operating activities	32,738	26,805
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	155,045	72,665
Purchases of investment securities available for sale	(164,052)	(232,633)
Proceeds from maturities of and calls on investment securities held to maturity	2,388	226
Net loan originations	(74,798)	(21,703)
Proceeds from sales of loans originated for investment	460
Proceeds from sale of other real estate	1,842	9,533
Proceeds from bank-owned life insurance		1,423
Purchases of premises and equipment	(1,337)	(519)
Distributions from unconsolidated subsidiaries	550	428
Contributions to unconsolidated subsidiaries	(50)
Proceeds from redemption of FHLB stock	434
Net cash used in investing activities	(79,518)	(170,580)
Cash flows from financing activities:
Net increase in deposits	83,919	64,275
Repayments of long-term debt	(5)	(50,004)
Net decrease in short-term borrowings		(34)
Net cash provided by financing activities	83,914	14,237
Net increase (decrease) in cash and cash equivalents	37,134	(129,538)
Cash and cash equivalents at beginning of period	177,375	257,072
Cash and cash equivalents at end of period	214,509	127,534
Cash paid during the period for:
Interest	14,048	1,787
Income taxes	5
Supplemental disclosure of noncash investing and financing activities:
Net change in common stock held by directors' deferred compensation plan	(7)	(35)
Net reclassification of loans to other real estate	640	544
Net transfer of loans to loans held for sale		$ 290

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.